Nan Fung Group Holdings as of Sept. 30, 2024
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 38 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Illumina (ILMN) | 13.4 | $16M | 119k | 130.41 | |
| Harmony Biosciences Hldgs In (HRMY) | 12.7 | $15M | 369k | 40.00 | |
| Geron Corporation (GERN) | 5.4 | $6.2M | 1.4M | 4.54 | |
| Merus N V (MRUS) | 5.2 | $6.0M | 120k | 49.96 | |
| Zai Lab Adr (ZLAB) | 4.9 | $5.7M | 235k | 24.14 | |
| Longboard Pharmaceuticals In (LBPH) | 4.6 | $5.4M | 161k | 33.33 | |
| Oculis Holding Ordinary Shares (OCS) | 4.6 | $5.3M | 436k | 12.26 | |
| Beigene Sponsored Adr (BGNE) | 4.5 | $5.2M | 23k | 224.51 | |
| Incyte Corporation (INCY) | 4.2 | $4.9M | 74k | 66.10 | |
| Xenon Pharmaceuticals (XENE) | 3.6 | $4.2M | 107k | 39.37 | |
| Exscientia Ads (EXAI) | 3.6 | $4.2M | 860k | 4.88 | |
| Mirum Pharmaceuticals (MIRM) | 3.6 | $4.1M | 106k | 39.00 | |
| Tourmaline Bio (TRML) | 3.3 | $3.8M | 147k | 25.71 | |
| D Fluidigm Corp Del (LAB) | 3.1 | $3.6M | 1.9M | 1.93 | |
| Soleno Therapeutics (SLNO) | 2.8 | $3.2M | 64k | 50.49 | |
| Replimune Group (REPL) | 2.7 | $3.2M | 288k | 10.96 | |
| Rhythm Pharmaceuticals (RYTM) | 2.2 | $2.6M | 49k | 52.39 | |
| Eliem Therapeutics (ELYM) | 2.0 | $2.4M | 464k | 5.09 | |
| Madrigal Pharmaceuticals (MDGL) | 1.8 | $2.1M | 9.8k | 212.22 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.7 | $2.0M | 14k | 149.31 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $1.8M | 155k | 11.58 | |
| Exelixis (EXEL) | 1.4 | $1.7M | 64k | 25.95 | |
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $1.6M | 103k | 15.38 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.9 | $1.1M | 494k | 2.16 | |
| Entrada Therapeutics (TRDA) | 0.7 | $784k | 49k | 15.98 | |
| BioMarin Pharmaceutical (BMRN) | 0.7 | $760k | 11k | 70.29 | |
| Bolt Biotherapeutics (BOLT) | 0.7 | $756k | 1.2M | 0.65 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $715k | 32k | 22.63 | |
| Bolt Projs Hldgs | 0.6 | $666k | 812k | 0.82 | |
| Kymera Therapeutics (KYMR) | 0.4 | $515k | 11k | 47.33 | |
| Revolution Medicines (RVMD) | 0.3 | $331k | 7.3k | 45.35 | |
| Springworks Therapeutics (SWTX) | 0.2 | $239k | 7.5k | 32.04 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $233k | 430.00 | 542.08 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $212k | 3.8k | 55.55 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.1 | $130k | 186k | 0.70 | |
| Affimed N V Ordinary Shs New (AFMD) | 0.1 | $125k | 37k | 3.36 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $100k | 48k | 2.09 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $76k | 42k | 1.82 |
